“Roflumilast Cream (ARQ-151) 0.15% and 0.3% Improved Burden of Signs and Symptoms in Adults With Chronic Plaque Psoriasis in a Phase 2b Study”. SKIN The Journal of Cutaneous Medicine, vol. 4, no. 6, Oct. 2020, p. s70, https://doi.org/10.25251/skin.4.supp.70.